🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Although PARP inhibitors (PARPi) have proved effective in treating many can...
Status
Completed
Location
Alexandre Joachim
Start Date
2020-02-09
Trial ID
NCT04326023
Treatments Being Tested
The purpose of this study is to characterize the mass balance, absorption, ...
Status
Completed
Location
PRA Magyarország Kft.
Start Date
2016-11
Trial ID
NCT02986100
Treatments Being Tested
Main Objective of this study is to examine long-term safety of nivolumab mo...
Status
Recruiting
Location
Local Institution - 0220
Start Date
2019-08-09
Trial ID
NCT03899155
A Phase 2, open-label, single-arm trial to evaluate the response of rucapar...
Status
Terminated
Location
UCLA Medicine Hematology and Oncology
Start Date
2020-01-16
Trial ID
NCT04171700
Treatments Being Tested
The objective of REVOCAN study is to assess the abrogation of PARP inhibito...
Status
Terminated
Location
CHU Jean Minjoz
Start Date
2020-10-05
Trial ID
NCT04826198
This is a prospective, non-randomized clinical trial that aims to describe ...
Status
Recruiting
Location
Noordwest ziekenhuisgroep Alkmaar (NWZ)
Start Date
2016-08
Trial ID
NCT02925234
Treatments Being Tested
This is a single arm, open label, phase II trial to assess efficacy of ruca...
Status
Terminated
Location
Huntsman Cancer Institute
Start Date
2019-05-20
Trial ID
NCT03533946
Treatments Being Tested
The aim of this research is to find out if the study drug rucaparib leads t...
Status
Completed
Location
Johns Hopkins Hospital
Start Date
2018-09-10
Trial ID
NCT03413995
Treatments Being Tested
This phase II Lung-MAP trial studies how well rucaparib works in treating p...
Status
Completed
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2019-04-16
Trial ID
NCT03845296
Treatments Being Tested
This is a Phase 3, randomized, multinational, double-blind, dual placebo-co...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - HAL
Start Date
2018-05-14
Trial ID
NCT03522246
Treatments Being Tested